FDA Approves Opus Genetics Eye Drops for Presbyopia
The approval expands use of an already commercialized therapy and triggers a milestone payment. The payment amount is not specified.
Opus Genetics (IRD) drew attention on Friday after the U.S. Food and Drug Administration approved its eye drop to treat presbyopia, an age-related condition that impairs near vision. The approval broadens the use of a therapy already on the market and triggers a…